| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |